Analysis by UALCAN showed that AGO2 was expressed at different levels in cases with multiple types of tumors, with a relatively large difference between normal tissues and tumors tissues in sarcoma cancer compared to other cancer types, indicating that a high AGO2 level is correlated with sarcoma progression (Figure 5A). This evidence concerns the gene AGO2 and sarcoma.